scholarly article | Q13442814 |
P2093 | author name string | Béliveau R | |
Gingras D | |||
Lamy S | |||
P2860 | cites work | Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues | Q22008806 |
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor | Q24323249 | ||
Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP | Q24324015 | ||
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth | Q24561921 | ||
Rho GTPases and the actin cytoskeleton | Q27860579 | ||
Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells | Q28240564 | ||
The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells | Q28257153 | ||
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 | ||
Bacterial toxins and the Rho GTP-binding protein: what microbes teach us about cell regulation | Q33592308 | ||
Flk-1 as a target for tumor growth inhibition. | Q34392604 | ||
Bacterial toxins that target Rho proteins | Q39779551 | ||
Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. | Q40400855 | ||
Vascular endothelial growth factor, a potent and selective angiogenic agent | Q40943215 | ||
Efficient gene transfer to human endothelial cells using DNA complexed to adenovirus particles | Q41014136 | ||
ADP-ribosylation of the G protein Rho inhibits integrin regulation of tumor cell growth | Q41197828 | ||
Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events | Q42457318 | ||
Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. | Q42799773 | ||
Cytotoxic necrotizing factor 1 from Escherichia coli and dermonecrotic toxin from Bordetella bronchiseptica induce p21(rho)-dependent tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 cells | Q42801859 | ||
Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation | Q42807654 | ||
A small GTP-binding protein, Rho, associates with the platelet-derived growth factor type-beta receptor upon ligand binding. | Q42825916 | ||
Dimerization as a regulatory mechanism in signal transduction | Q46409691 | ||
Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor | Q46693604 | ||
Rho GTPases | Q47724821 | ||
Post-transcriptional regulation of vascular endothelial growth factor by hypoxia | Q48066359 | ||
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. | Q50626711 | ||
Escherichia coli cytotoxic necrotizing factor 1 (CNF1), a toxin that activates the Rho GTPase. | Q54561665 | ||
Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. | Q54564124 | ||
Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. | Q55065488 | ||
Dissection of Pathways Implicated in Integrin-mediated Actin Cytoskeleton Assembly | Q60716522 | ||
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression | Q71802927 | ||
Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization | Q73316445 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | phosphorylation | Q242736 |
endothelium | Q111140 | ||
P304 | page(s) | 273-280 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Biochemical Journal | Q864221 |
P1476 | title | Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins | |
P478 | volume | 348 Pt 2 |
Q51590807 | 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. |
Q33512121 | A new procedure for determining the genetic basis of a physiological process in a non-model species, illustrated by cold induced angiogenesis in the carp |
Q43162316 | Antiangiogenic mechanisms of simvastatin in retinal endothelial cells |
Q36131307 | Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer |
Q26250150 | Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis |
Q36561736 | Multifaceted role of Rho proteins in angiogenesis |
Q35603936 | NO and angiogenesis |
Q38720808 | Penduliflaworosin, a Diterpenoid from Croton crassifolius, Exerts Anti-Angiogenic Effect via VEGF Receptor-2 Signaling Pathway. |
Q39294147 | Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions |
Q34774011 | Regulation of microvascular permeability by vascular endothelial growth factors |
Q34451462 | Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. |
Q35127972 | Regulation of vascular permeability by vascular endothelial growth factors. |
Q35127959 | Rho GTPases and the regulation of endothelial permeability |
Q38384340 | RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy |
Q44604699 | Second hand smoke stimulates tumor angiogenesis and growth |
Q37734546 | The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development |
Q44275819 | Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions |
Search more.